Prognostic role of pretreatment skeletal muscle index in gastric cancer patients: A meta-analysis

Background: The association between pretreatment skeletal muscle index (SMI) and long-term survival of gastric cancer patients remains unclear up to now. The aim of this meta-analysis was to identify the prognostic value of pretreatment SMI in gastric cancer. Methods: The PubMed, EMBASE and Web of Science electronic databases were searched up to 5 June 2022 for relevant studies. The primary outcome was overall survival (OS) and the second outcomes were disease-free survival (DFS) and cancer-specific survival (CSS). The hazard ratios (HRs) and 95% confidence intervals (CIs) were combined to assess the relationship between pretreatment SMI and survival of gastric cancer patients. All statistical analyses were conducted by STATA 15.0 software. Results: A total of 31 retrospective studies involving 12,434 patients were enrolled in this meta-analysis. The pooled results demonstrated that lower pretreatment was significantly associated with poorer OS (HR = 1.53, p < 0.001). Besides, lower pretreatment SMI was also related with worse DFS (HR = 1.39, p < 0.001) and CSS (HR = 1.96, p < 0.001). Conclusion: Pretreatment SMI was significantly associated with prognosis of gastric cancer patients and lower SMI predicted worse survival. However, more prospective high-quality studies are still needed to verify our findings.

[1]  J. Johansen,et al.  The prevalence of sarcopenia and cachexia in older patients with localized colorectal cancer. , 2022, Journal of geriatric oncology.

[2]  D. Santoro,et al.  The Effect of Nutrition and Exercise on Body Composition, Exercise Capacity, and Physical Functioning in Advanced CKD Patients , 2022, Nutrients.

[3]  Xiangguo Che,et al.  Skeletal muscle mitoribosomal defects are linked to low bone mass caused by bone marrow inflammation in male mice , 2022, Journal of cachexia, sarcopenia and muscle.

[4]  San-Gang Wu,et al.  Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy , 2022, BMC cancer.

[5]  N. Inaki,et al.  Impact of diabetes mellitus on long-term prognosis after gastrectomy for advanced gastric cancer: a propensity score matching analysis , 2022, Surgery Today.

[6]  H. Eguchi,et al.  Perioperative Ghrelin Administration Attenuates Postoperative Skeletal Muscle Loss in Patients Undergoing Esophagectomy for Esophageal Cancer: Secondary Analysis of a Randomized Controlled Trial , 2022, Annals of Surgical Oncology.

[7]  A. Cansu,et al.  Effects of Sarcopenia on Postoperative Outcomes in Patients Who Underwent Gastrectomy for Gastric Cancer. , 2022, The Journal of surgical research.

[8]  Won-Seok Kim,et al.  Risk factors and clinical outcomes of postgastrectomy sarcopenia newly developed after curative resection for gastric cancer , 2022, Medicine.

[9]  A. Tranoulis,et al.  Prevalence of computed tomography-based sarcopenia and the prognostic value of skeletal muscle index and muscle attenuation amongst women with epithelial ovarian malignancy: A systematic review and meta-analysis. , 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  Y. Li,et al.  Association of Sarcopenia and Expression of Interleukin-16 in Gastric Cancer Survival , 2022, Nutrients.

[11]  A. Fiorelli,et al.  The Potential Role of Nutrition in Lung Cancer Establishment and Progression , 2022, Life.

[12]  Guohao Wu,et al.  Postoperative Loss of Skeletal Muscle Mass Predicts Poor Survival After Gastric Cancer Surgery , 2022, Frontiers in Nutrition.

[13]  Ze-Xin Huang,et al.  Effect of Short-Term Preoperative Parenteral Nutrition Support for Gastric Cancer Patients with Sarcopenia: a Propensity Score Matching Analysis , 2022, Journal of Gastrointestinal Surgery.

[14]  Qianqian Gao,et al.  Impact of preoperative sarcopenia on postoperative complications and survival outcomes of patients with esophageal cancer: a meta-analysis of cohort studies. , 2022, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[15]  N. Yamamichi,et al.  The impact of sarcopenia on adverse events associated with gastric endoscopic submucosal dissection , 2022, Surgical Endoscopy.

[16]  Tze‐Chien Chen,et al.  Progressive Skeletal Muscle Loss After Surgery and Adjuvant Radiotherapy Impact Survival Outcomes in Patients With Early Stage Cervical Cancer , 2022, Frontiers in Nutrition.

[17]  Y. Seto,et al.  The type of gastrectomy affects skeletal muscle loss and the long-term outcomes of elderly patients with gastric cancer: a retrospective study using computed tomography images , 2021, Surgery Today.

[18]  C. Celis-Morales,et al.  Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis , 2021, Journal of cachexia, sarcopenia and muscle.

[19]  Y. Fujiwara,et al.  Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil , 2021, BMC Cancer.

[20]  Y. Takenaka,et al.  Prognostic impact of sarcopenia in patients with head and neck cancer treated with surgery or radiation: A meta-analysis , 2021, PloS one.

[21]  A. Pecchi,et al.  Strong impact of sarcopenia as a risk factor of survival in resected gastric cancer patients: first Italian report of a Bicentric study , 2021, Updates in Surgery.

[22]  A. Gasbarrini,et al.  The prognostic value of skeletal muscle index on clinical and survival outcomes after cytoreduction and HIPEC for peritoneal metastases from colorectal cancer: A systematic review and meta-analysis. , 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  Sang-Hoon Ahn,et al.  Prognostic significance of surgery‐induced sarcopenia in the survival of gastric cancer patients: a sex‐specific analysis , 2021, Journal of cachexia, sarcopenia and muscle.

[24]  S. Han,et al.  Detection of sarcopenic obesity and prediction of long‐term survival in patients with gastric cancer using preoperative computed tomography and machine learning , 2021, Journal of surgical oncology.

[25]  C. Verhoef,et al.  Sarcopenia and long-term survival outcomes after local therapy for colorectal liver metastasis: a meta-analysis. , 2021, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[26]  K. Maeda,et al.  Depletion of skeletal muscle mass adversely affects long-term outcomes for men undergoing gastrectomy for gastric cancer , 2021, PloS one.

[27]  W. Eo,et al.  Muscle-Related Parameters as Determinants of Survival in Patients with Stage I-III Gastric Cancer Undergoing Gastrectomy , 2021, Journal of Cancer.

[28]  K. Higuchi,et al.  Pathophysiology and mechanisms of primary sarcopenia (Review). , 2021, International journal of molecular medicine.

[29]  F. Piacentini,et al.  The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center , 2021, Journal of clinical medicine.

[30]  Wanqing Chen,et al.  Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020 , 2021, Chinese medical journal.

[31]  Qian-tong Dong,et al.  The relationship between the GLIM-defined malnutrition, body composition and functional parameters, and clinical outcomes in elderly patients undergoing radical gastrectomy for gastric cancer. , 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[32]  T. Sutherland,et al.  Pre‐operative low muscle mass is associated with major complications and lower recurrence‐free survival after gastric cancer surgery , 2021, ANZ journal of surgery.

[33]  Taeyong Park,et al.  Preoperative nutritional risk index and postoperative one-year skeletal muscle loss can predict the prognosis of patients with gastric adenocarcinoma: a registry-based study , 2021, BMC Cancer.

[34]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[35]  H. Kanemoto,et al.  Preoperative skeletal muscle index and visceral-to-subcutaneous fat area ratio are associated with long-term outcomes of elderly gastric cancer patients after gastrectomy , 2021, Langenbeck's Archives of Surgery.

[36]  A. Pár,et al.  Sarcopenia - 2021: Pathophysiology, diagnosis, therapy , 2021, Orvosi hetilap.

[37]  Boran Cheng,et al.  Prognostic impact of sarcopenia on immune-related adverse events in malignancies received immune checkpoint inhibitors: a systematic review and meta-analysis , 2021, Translational cancer research.

[38]  E. Y. Kim,et al.  Body mass index and skeletal muscle index are useful prognostic factors for overall survival after gastrectomy for gastric cancer , 2020, Medicine.

[39]  Zhao Zhang,et al.  Influence of body composition, muscle strength, and physical performance on the postoperative complications and survival after radical gastrectomy for gastric cancer: A comprehensive analysis from a large-scale prospective study. , 2020, Clinical nutrition.

[40]  R. Langen,et al.  Inflammation and Skeletal Muscle Wasting During Cachexia , 2020, Frontiers in Physiology.

[41]  Chang-ming Huang,et al.  Effect of sarcopenia on short- and long-term outcomes in patients with gastric neuroendocrine neoplasms after radical gastrectomy: results from a large, two-institution series , 2020, BMC Cancer.

[42]  Yunmei Yang,et al.  Preoperative computed tomography-assessed skeletal muscle index is a novel prognostic factor in patients with hepatocellular carcinoma following hepatectomy: a meta-analysis. , 2020, Journal of gastrointestinal oncology.

[43]  I. Sohn,et al.  Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors , 2020, Gastric Cancer.

[44]  S. Park,et al.  Effect of baseline sarcopenia on adjuvant treatment for D2 dissected gastric cancer: Analysis of the ARTIST phase III trial. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[45]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[46]  Chang-ming Huang,et al.  Effect of sarcopenia on short- and long-term outcomes in patients with gastric neuroendocrine neoplasms after radical gastrectomy: results from a large, two-institution series , 2020, BMC cancer.

[47]  Jiazhou Wang,et al.  Quantifying skeletal muscle wasting during chemoradiotherapy with Jacobian calculations for the prediction of survival and toxicity in patients with gastric cancer. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[48]  Qian-tong Dong,et al.  EWGSOP2 versus EWGSOP1 for sarcopenia to predict prognosis in patients with gastric cancer after radical gastrectomy: Analysis from a large-scale prospective study. , 2019, Clinical nutrition.

[49]  J. Ijzermans,et al.  Prognostic significance of the controlling nutritional status (CONUT) score in patients undergoing gastrectomy for gastric cancer: a systematic review and meta-analysis , 2019, BMC Surgery.

[50]  M. Sierzega,et al.  Prognostic and predictive implications of sarcopenia in Western patients undergoing gastric resections for carcinoma of the stomach , 2019, Journal of surgical oncology.

[51]  Yan Wang,et al.  Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Non-Small Cell Lung Cancer: A Meta-Analysis , 2019, Oncology Research and Treatment.

[52]  Xi-Yi Chen,et al.  Myosteatosis predicts prognosis after radical gastrectomy for gastric cancer: A propensity score-matched analysis from a large-scale cohort. , 2019, Surgery.

[53]  K. Muro,et al.  Baseline Sarcopenia and Skeletal Muscle Loss During Chemotherapy Affect Survival Outcomes in Metastatic Gastric Cancer , 2018, AntiCancer Research.

[54]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[55]  M. Maher,et al.  Sarcopenia and Post-Operative Morbidity and Mortality in Patients with Gastric Cancer , 2018, Journal of gastric cancer.

[56]  Young Saing Kim,et al.  Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer , 2018, PloS one.

[57]  Su Jin Heo,et al.  Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial , 2018, Annals of Surgical Oncology.

[58]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[59]  V. Baracos,et al.  Body Composition as a Prognostic Factor of Neoadjuvant Chemotherapy Toxicity and Outcome in Patients with Locally Advanced Gastric Cancer , 2017, Journal of gastric cancer.

[60]  Chang-ming Huang,et al.  A Novel Prognostic Scoring System Based on Preoperative Sarcopenia Predicts the Long-Term Outcome for Patients After R0 Resection for Gastric Cancer: Experiences of a High-Volume Center , 2017, Annals of Surgical Oncology.

[61]  Manuela Merli,et al.  Sarcopenia from mechanism to diagnosis and treatment in liver disease. , 2016, Journal of hepatology.

[62]  P. Gao,et al.  The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysis. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[63]  Hui-Yi Lin,et al.  Role of Prognostic Nutritional Index in patients with gastric cancer: a meta-analysis. , 2016, Minerva medica.

[64]  Cheng-Le Zhuang,et al.  Sarcopenia is an Independent Predictor of Severe Postoperative Complications and Long-Term Survival After Radical Gastrectomy for Gastric Cancer , 2016, Medicine.

[65]  Y. Kodera,et al.  Low skeletal muscle density is associated with poor survival in patients who receive chemotherapy for metastatic gastric cancer. , 2016, Oncology reports.

[66]  M. Sandri,et al.  Mechanisms regulating skeletal muscle growth and atrophy , 2013, The FEBS journal.

[67]  K. McLeroy,et al.  Reporting guidelines and the American Journal of Public Health's adoption of Preferred Reporting Items for Systematic reviews and Meta-Analyses. , 2012, American journal of public health.

[68]  D. Lobo,et al.  Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. , 2012, Clinical nutrition.

[69]  A. Stang.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[70]  F. Schmidt.  Meta-Analysis , 2008 .

[71]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[72]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[73]  I. Chervoneva,et al.  Secondary Analysis of a Randomized Controlled Trial of Intranasal Corticosteroids in the Treatment of Mild to Moderate Pediatric Obstructive Sleep Apnea , 2022, TP73. TP073 PEDIATRIC SLEEP.